Nanoncology: A state-of-art update

V. S. Joo, T. G. Ramasamy, R. Murugan, Z. S. Haidar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Nanoscale drug delivery applications in cancer therapeutics, termed as nanoncology, are being utilized to resolve recurring problems in conventional drug delivery. Nanoparticles have properties unlike their bulk counterparts and the ongoing development of these characteristics continues to increase the repertoire of bio-functionality in regards to interactions of oncotic cellular and molecular systems. Nanoparticles can be constructed in a manner that is tunable and targeted, which gives standard chemotherapy a new approach in terms of drug administration and lowering off-target toxicities. This work concisely discusses pivotal factors in nanoparticle characteristics for cancer therapy providing an up-to-date therapeutics platforms review.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalJournal of Bionanoscience
Issue number1-2
StatePublished - Jun 2010
Externally publishedYes


  • Cancer
  • Chemotherapy
  • Drug Delivery
  • Nanobiotechnology
  • Nanoncology
  • Nanoparticle
  • Oncology
  • Polymers
  • Therapy
  • Tumor


Dive into the research topics of 'Nanoncology: A state-of-art update'. Together they form a unique fingerprint.

Cite this